摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[Ni4(2,4,6-tris(bis(pyridin-2-yl)amino)-1,3,5-triazine)2(NO3)8] C66H48N32Ni4O24, monoclinic | 940298-79-3

中文名称
——
中文别名
——
英文名称
[Ni4(2,4,6-tris(bis(pyridin-2-yl)amino)-1,3,5-triazine)2(NO3)8] C66H48N32Ni4O24, monoclinic
英文别名
[Ni4(2,4,6-tris(bis(pyridin-2-yl)amino)-1,3,5-triazine)2(NO3)8];[Ni4(2,4,6-tris(bis(pyridin-2-yl)amino)-1,3,5-triazine)2(NO3)8] C66H48N32Ni4O24, triclinic
[Ni4(2,4,6-tris(bis(pyridin-2-yl)amino)-1,3,5-triazine)2(NO3)8] C66H48N32Ni4O24, monoclinic化学式
CAS
940298-79-3
化学式
C66H48N32Ni4O24
mdl
——
分子量
1908.07
InChiKey
YJNKWFCQSHNOTD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    [Ni4(2,4,6-tris(bis(pyridin-2-yl)amino)-1,3,5-triazine)2(NO3)8] C66H48N32Ni4O24, monoclinic 以 neat (no solvent) 为溶剂, 生成 [Ni4(2,4,6-tris(bis(pyridin-2-yl)amino)-1,3,5-triazine)2(NO3)8(H2O)4]*8H2O
    参考文献:
    名称:
    Rich Pseudopolymorphic Behavior of the Tetranuclear [Ni4(dpyatriz)2(NO3)8] Complex
    摘要:
    Reaction of nickel(II) nitrate with the dpyatriz ligand, namely 2,4,6-tris(bis(pyridin-2-yl)amino)-1,3,5-triazine, in acetonitrile produces a tetranuclear Ni-II coordination compound, [Ni-4(dpyatriz)(2)(NO3)(8)(CH3CN)(2)(H2O)(2)]center dot 2CH(3)CN (1), the crystal structure of which has been determined by X-ray diffraction using a synchrotron source. 1 has been characterized by IR and UV-vis spectroscopy, elemental and thermogravimetric analyses, and magnetic susceptibility measurements. Its solid-state structure exhibits remarkable anion center dot center dot center dot pi interactions between coordinated nitrate ions and the triazine rings. In addition, a thorough X-ray powder diffraction study has revealed a number of pseudopolymorphic phases (2-5), resulting from various degrees of hydration/solvation of the [Ni-4(dpyatriz)(2)] core. The interconversion scheme among the different phases has been determined using controlled heating, and the basic structural features of the different pseudopolymorphs have been assessed through ab initio powder diffraction methods.
    DOI:
    10.1021/ic0702015
  • 作为产物:
    描述:
    [Ni4(2,4,6-tris(bis(pyridin-2-yl)amino)-1,3,5-triazine)2(NO3)8(H2O)4]*8H2O 以 neat (no solvent) 为溶剂, 生成 [Ni4(2,4,6-tris(bis(pyridin-2-yl)amino)-1,3,5-triazine)2(NO3)8] C66H48N32Ni4O24, monoclinic
    参考文献:
    名称:
    Rich Pseudopolymorphic Behavior of the Tetranuclear [Ni4(dpyatriz)2(NO3)8] Complex
    摘要:
    Reaction of nickel(II) nitrate with the dpyatriz ligand, namely 2,4,6-tris(bis(pyridin-2-yl)amino)-1,3,5-triazine, in acetonitrile produces a tetranuclear Ni-II coordination compound, [Ni-4(dpyatriz)(2)(NO3)(8)(CH3CN)(2)(H2O)(2)]center dot 2CH(3)CN (1), the crystal structure of which has been determined by X-ray diffraction using a synchrotron source. 1 has been characterized by IR and UV-vis spectroscopy, elemental and thermogravimetric analyses, and magnetic susceptibility measurements. Its solid-state structure exhibits remarkable anion center dot center dot center dot pi interactions between coordinated nitrate ions and the triazine rings. In addition, a thorough X-ray powder diffraction study has revealed a number of pseudopolymorphic phases (2-5), resulting from various degrees of hydration/solvation of the [Ni-4(dpyatriz)(2)] core. The interconversion scheme among the different phases has been determined using controlled heating, and the basic structural features of the different pseudopolymorphs have been assessed through ab initio powder diffraction methods.
    DOI:
    10.1021/ic0702015
点击查看最新优质反应信息

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯